OCULOXIN® is a unique blend of standardized extracts from Vaccinium myrtillus L., Aronia Melanocarpa, and Lonicera caerulea var. Kamtschatica, designed to enhance visual health. This innovative formula features a synergistic mix of polyphenols, including anthocyanins, and iridoids, optimized to improve various visual parameters. Sourced from local, controlled plantations in Poland, OCULOXIN® guarantees high-quality extracts. The production involves double standardization, ensuring anthocyanins content of at least 25% and iridoids of no less than 2%. Recommended for those experiencing eye strain from screens, presbyopia, early diabetic retinopathy, or asthenopia, the suggested dose is 150-200 mg twice daily.
Daily Italian Coffee Habit May Cut MASLD Risk by Over 50%
April 10, 2026
